Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit

OBJECTIVE To more clearly define the relationships between plasma proinflammatory cytokine concentrations, physiologic disturbance, and survival in severely ill patients. DESIGN Prospective, longitudinal, cohort analytic study. SETTING Teaching hospital intensive care unit (ICU). PATIENTS Two hundre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care medicine 1996-11, Vol.24 (11), p.1775-1781
Hauptverfasser: Friedland, Jon S, Porter, Joanna C, Daryanani, Sunil, Bland, J. Martin, Screaton, Nicholas J, Vesely, Martin J. J, Griffin, George E, Bennett, E. David, Remick, Daniel G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1781
container_issue 11
container_start_page 1775
container_title Critical care medicine
container_volume 24
creator Friedland, Jon S
Porter, Joanna C
Daryanani, Sunil
Bland, J. Martin
Screaton, Nicholas J
Vesely, Martin J. J
Griffin, George E
Bennett, E. David
Remick, Daniel G
description OBJECTIVE To more clearly define the relationships between plasma proinflammatory cytokine concentrations, physiologic disturbance, and survival in severely ill patients. DESIGN Prospective, longitudinal, cohort analytic study. SETTING Teaching hospital intensive care unit (ICU). PATIENTS Two hundred fifty-one consecutive nonselected patients admitted to the ICU. INTERVENTIONS None. MEASUREMENTS AND MAIN RESULTS Daily Acute Physiology and Chronic Health Evaluation (APACHE) III scores were calculated from clinical and laboratory data. In concurrent blood samples, plasma concentrations were measured of four proinflammatory cytokines (tumor necrosis factor-[TNF] alpha, interleukin [IL]-1 beta, IL-6, and IL-8), all of which are believed to be of central importance in host proinflammatory and immune responses. Plasma TNF concentrations were increased in 42 patients, plasma IL-1 beta in 15 patients, IL-6 in 194 patients, and IL-8 in 52 patients at presentation. Although admission plasma IL-1 beta, IL-6, and IL-8 concentrations were higher in patients who died in the ICU compared with survivors (n = 33; p < .02, p < .01, p < .02, respectively), only admission plasma IL-8 concentrations were higher in patients with a fatal outcome if all in-hospital deaths were considered (n = 53; p = .05). APACHE III score was the best predictor of mortality (odds ratio 11.41; p = .003). Detection, but not the absolute level, of TNF bioactivity in plasma was a weak independent predictor of death (odds ratio 3.17; p = .02). There was no relationship between bacteremia or presence of the systemic inflammatory response syndrome and plasma cytokine concentrations. Nineteen patients were in the ICU for >or=to10 days, and of these 19 patients, 16 patients had prolonged increases of plasma cytokines. Two patients with persistently increased plasma TNF concentrations died. Otherwise, persistently increased plasma cytokine concentrations had a variable relation to daily APACHE scores and to mortality. CONCLUSIONS Plasma cytokine concentrations fluctuate in serious illness and have a poor correlation with derangement of whole body physiology in seriously ill patients. Only the presence of bioactive TNF in plasma was an independent predictor of mortality. Daily measurement of plasma proinflammatory cytokine concentrations is unlikely to have clinical application in the ICU setting, except possibly in specific subgroups of patients.(Crit Care Med 1996; 24:1775-1781)
doi_str_mv 10.1097/00003246-199611000-00003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78536075</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78536075</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4793-282de3bc15ac2ee66f421797f7a85c32715babe203c8aa0c270bc99bdd28cf093</originalsourceid><addsrcrecordid>eNp1ksuO0zAUhi0EGsrAIyB5gdAgEfAlieNlVRVaaSS6gHV04jjUjGMX2-koD8R74mlLd3hhn8v3-0j-jRCm5BMlUnwmeXFW1gWVsqY0Z8Wp9AwtaMVzwiR_jhaESFLwUvKX6FWMvwihZSX4DbppJBWElQv0Z2chjoAPwRs3WBhHSD7MWM3JPxinsfJOaZcCJONd_IiXakoa7_ZzNN76nzMG1-PVPnhnFN5osGmP10ew00mA75a75Wqz_oC32y2OygcdT4o4haPJGDYOHzKaR8SnGFzek3bRHPNsCBpPzqTX6MUANuo3l_MW_fiy_r7aFPffvm5Xy_tClULygjWs17xTtALFtK7roWRUSDEIaCrFmaBVB51mhKsGgCgmSKek7PqeNWogkt-i9-d783P8nnRM7Wii0taC036KrWgqXhNRZbA5gyr4GIMe2kMwI4S5paR9cqj951B7dehcytK3lxlTN-r-KrxYkvvvLn2ICuwQwCkTrxgrm7rmLGPlGXv0NukQH-z0qEO7PznQ_u9_8L8Eoqqy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78536075</pqid></control><display><type>article</type><title>Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Friedland, Jon S ; Porter, Joanna C ; Daryanani, Sunil ; Bland, J. Martin ; Screaton, Nicholas J ; Vesely, Martin J. J ; Griffin, George E ; Bennett, E. David ; Remick, Daniel G</creator><creatorcontrib>Friedland, Jon S ; Porter, Joanna C ; Daryanani, Sunil ; Bland, J. Martin ; Screaton, Nicholas J ; Vesely, Martin J. J ; Griffin, George E ; Bennett, E. David ; Remick, Daniel G</creatorcontrib><description>OBJECTIVE To more clearly define the relationships between plasma proinflammatory cytokine concentrations, physiologic disturbance, and survival in severely ill patients. DESIGN Prospective, longitudinal, cohort analytic study. SETTING Teaching hospital intensive care unit (ICU). PATIENTS Two hundred fifty-one consecutive nonselected patients admitted to the ICU. INTERVENTIONS None. MEASUREMENTS AND MAIN RESULTS Daily Acute Physiology and Chronic Health Evaluation (APACHE) III scores were calculated from clinical and laboratory data. In concurrent blood samples, plasma concentrations were measured of four proinflammatory cytokines (tumor necrosis factor-[TNF] alpha, interleukin [IL]-1 beta, IL-6, and IL-8), all of which are believed to be of central importance in host proinflammatory and immune responses. Plasma TNF concentrations were increased in 42 patients, plasma IL-1 beta in 15 patients, IL-6 in 194 patients, and IL-8 in 52 patients at presentation. Although admission plasma IL-1 beta, IL-6, and IL-8 concentrations were higher in patients who died in the ICU compared with survivors (n = 33; p &lt; .02, p &lt; .01, p &lt; .02, respectively), only admission plasma IL-8 concentrations were higher in patients with a fatal outcome if all in-hospital deaths were considered (n = 53; p = .05). APACHE III score was the best predictor of mortality (odds ratio 11.41; p = .003). Detection, but not the absolute level, of TNF bioactivity in plasma was a weak independent predictor of death (odds ratio 3.17; p = .02). There was no relationship between bacteremia or presence of the systemic inflammatory response syndrome and plasma cytokine concentrations. Nineteen patients were in the ICU for &gt;or=to10 days, and of these 19 patients, 16 patients had prolonged increases of plasma cytokines. Two patients with persistently increased plasma TNF concentrations died. Otherwise, persistently increased plasma cytokine concentrations had a variable relation to daily APACHE scores and to mortality. CONCLUSIONS Plasma cytokine concentrations fluctuate in serious illness and have a poor correlation with derangement of whole body physiology in seriously ill patients. Only the presence of bioactive TNF in plasma was an independent predictor of mortality. Daily measurement of plasma proinflammatory cytokine concentrations is unlikely to have clinical application in the ICU setting, except possibly in specific subgroups of patients.(Crit Care Med 1996; 24:1775-1781)</description><identifier>ISSN: 0090-3493</identifier><identifier>EISSN: 1530-0293</identifier><identifier>DOI: 10.1097/00003246-199611000-00003</identifier><identifier>PMID: 8917024</identifier><identifier>CODEN: CCMDC7</identifier><language>eng</language><publisher>Hagerstown, MD: Williams &amp; Wilkins</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; APACHE ; Biological and medical sciences ; Cohort Studies ; Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care ; Female ; Humans ; Intensive care medicine ; Intensive Care Units ; Interleukins - blood ; Longitudinal Studies ; Male ; Medical sciences ; Middle Aged ; Predictive Value of Tests ; Prognosis ; Prospective Studies ; Survival Rate ; Systemic Inflammatory Response Syndrome - blood ; Systemic Inflammatory Response Syndrome - mortality ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>Critical care medicine, 1996-11, Vol.24 (11), p.1775-1781</ispartof><rights>Williams &amp; Wilkins 1996. All Rights Reserved.</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4793-282de3bc15ac2ee66f421797f7a85c32715babe203c8aa0c270bc99bdd28cf093</citedby><cites>FETCH-LOGICAL-c4793-282de3bc15ac2ee66f421797f7a85c32715babe203c8aa0c270bc99bdd28cf093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2486632$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8917024$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Friedland, Jon S</creatorcontrib><creatorcontrib>Porter, Joanna C</creatorcontrib><creatorcontrib>Daryanani, Sunil</creatorcontrib><creatorcontrib>Bland, J. Martin</creatorcontrib><creatorcontrib>Screaton, Nicholas J</creatorcontrib><creatorcontrib>Vesely, Martin J. J</creatorcontrib><creatorcontrib>Griffin, George E</creatorcontrib><creatorcontrib>Bennett, E. David</creatorcontrib><creatorcontrib>Remick, Daniel G</creatorcontrib><title>Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit</title><title>Critical care medicine</title><addtitle>Crit Care Med</addtitle><description>OBJECTIVE To more clearly define the relationships between plasma proinflammatory cytokine concentrations, physiologic disturbance, and survival in severely ill patients. DESIGN Prospective, longitudinal, cohort analytic study. SETTING Teaching hospital intensive care unit (ICU). PATIENTS Two hundred fifty-one consecutive nonselected patients admitted to the ICU. INTERVENTIONS None. MEASUREMENTS AND MAIN RESULTS Daily Acute Physiology and Chronic Health Evaluation (APACHE) III scores were calculated from clinical and laboratory data. In concurrent blood samples, plasma concentrations were measured of four proinflammatory cytokines (tumor necrosis factor-[TNF] alpha, interleukin [IL]-1 beta, IL-6, and IL-8), all of which are believed to be of central importance in host proinflammatory and immune responses. Plasma TNF concentrations were increased in 42 patients, plasma IL-1 beta in 15 patients, IL-6 in 194 patients, and IL-8 in 52 patients at presentation. Although admission plasma IL-1 beta, IL-6, and IL-8 concentrations were higher in patients who died in the ICU compared with survivors (n = 33; p &lt; .02, p &lt; .01, p &lt; .02, respectively), only admission plasma IL-8 concentrations were higher in patients with a fatal outcome if all in-hospital deaths were considered (n = 53; p = .05). APACHE III score was the best predictor of mortality (odds ratio 11.41; p = .003). Detection, but not the absolute level, of TNF bioactivity in plasma was a weak independent predictor of death (odds ratio 3.17; p = .02). There was no relationship between bacteremia or presence of the systemic inflammatory response syndrome and plasma cytokine concentrations. Nineteen patients were in the ICU for &gt;or=to10 days, and of these 19 patients, 16 patients had prolonged increases of plasma cytokines. Two patients with persistently increased plasma TNF concentrations died. Otherwise, persistently increased plasma cytokine concentrations had a variable relation to daily APACHE scores and to mortality. CONCLUSIONS Plasma cytokine concentrations fluctuate in serious illness and have a poor correlation with derangement of whole body physiology in seriously ill patients. Only the presence of bioactive TNF in plasma was an independent predictor of mortality. Daily measurement of plasma proinflammatory cytokine concentrations is unlikely to have clinical application in the ICU setting, except possibly in specific subgroups of patients.(Crit Care Med 1996; 24:1775-1781)</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>APACHE</subject><subject>Biological and medical sciences</subject><subject>Cohort Studies</subject><subject>Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care</subject><subject>Female</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Intensive Care Units</subject><subject>Interleukins - blood</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Prospective Studies</subject><subject>Survival Rate</subject><subject>Systemic Inflammatory Response Syndrome - blood</subject><subject>Systemic Inflammatory Response Syndrome - mortality</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>0090-3493</issn><issn>1530-0293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1ksuO0zAUhi0EGsrAIyB5gdAgEfAlieNlVRVaaSS6gHV04jjUjGMX2-koD8R74mlLd3hhn8v3-0j-jRCm5BMlUnwmeXFW1gWVsqY0Z8Wp9AwtaMVzwiR_jhaESFLwUvKX6FWMvwihZSX4DbppJBWElQv0Z2chjoAPwRs3WBhHSD7MWM3JPxinsfJOaZcCJONd_IiXakoa7_ZzNN76nzMG1-PVPnhnFN5osGmP10ew00mA75a75Wqz_oC32y2OygcdT4o4haPJGDYOHzKaR8SnGFzek3bRHPNsCBpPzqTX6MUANuo3l_MW_fiy_r7aFPffvm5Xy_tClULygjWs17xTtALFtK7roWRUSDEIaCrFmaBVB51mhKsGgCgmSKek7PqeNWogkt-i9-d783P8nnRM7Wii0taC036KrWgqXhNRZbA5gyr4GIMe2kMwI4S5paR9cqj951B7dehcytK3lxlTN-r-KrxYkvvvLn2ICuwQwCkTrxgrm7rmLGPlGXv0NukQH-z0qEO7PznQ_u9_8L8Eoqqy</recordid><startdate>199611</startdate><enddate>199611</enddate><creator>Friedland, Jon S</creator><creator>Porter, Joanna C</creator><creator>Daryanani, Sunil</creator><creator>Bland, J. Martin</creator><creator>Screaton, Nicholas J</creator><creator>Vesely, Martin J. J</creator><creator>Griffin, George E</creator><creator>Bennett, E. David</creator><creator>Remick, Daniel G</creator><general>Williams &amp; Wilkins</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199611</creationdate><title>Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit</title><author>Friedland, Jon S ; Porter, Joanna C ; Daryanani, Sunil ; Bland, J. Martin ; Screaton, Nicholas J ; Vesely, Martin J. J ; Griffin, George E ; Bennett, E. David ; Remick, Daniel G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4793-282de3bc15ac2ee66f421797f7a85c32715babe203c8aa0c270bc99bdd28cf093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>APACHE</topic><topic>Biological and medical sciences</topic><topic>Cohort Studies</topic><topic>Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care</topic><topic>Female</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Intensive Care Units</topic><topic>Interleukins - blood</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Prospective Studies</topic><topic>Survival Rate</topic><topic>Systemic Inflammatory Response Syndrome - blood</topic><topic>Systemic Inflammatory Response Syndrome - mortality</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Friedland, Jon S</creatorcontrib><creatorcontrib>Porter, Joanna C</creatorcontrib><creatorcontrib>Daryanani, Sunil</creatorcontrib><creatorcontrib>Bland, J. Martin</creatorcontrib><creatorcontrib>Screaton, Nicholas J</creatorcontrib><creatorcontrib>Vesely, Martin J. J</creatorcontrib><creatorcontrib>Griffin, George E</creatorcontrib><creatorcontrib>Bennett, E. David</creatorcontrib><creatorcontrib>Remick, Daniel G</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Friedland, Jon S</au><au>Porter, Joanna C</au><au>Daryanani, Sunil</au><au>Bland, J. Martin</au><au>Screaton, Nicholas J</au><au>Vesely, Martin J. J</au><au>Griffin, George E</au><au>Bennett, E. David</au><au>Remick, Daniel G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit</atitle><jtitle>Critical care medicine</jtitle><addtitle>Crit Care Med</addtitle><date>1996-11</date><risdate>1996</risdate><volume>24</volume><issue>11</issue><spage>1775</spage><epage>1781</epage><pages>1775-1781</pages><issn>0090-3493</issn><eissn>1530-0293</eissn><coden>CCMDC7</coden><abstract>OBJECTIVE To more clearly define the relationships between plasma proinflammatory cytokine concentrations, physiologic disturbance, and survival in severely ill patients. DESIGN Prospective, longitudinal, cohort analytic study. SETTING Teaching hospital intensive care unit (ICU). PATIENTS Two hundred fifty-one consecutive nonselected patients admitted to the ICU. INTERVENTIONS None. MEASUREMENTS AND MAIN RESULTS Daily Acute Physiology and Chronic Health Evaluation (APACHE) III scores were calculated from clinical and laboratory data. In concurrent blood samples, plasma concentrations were measured of four proinflammatory cytokines (tumor necrosis factor-[TNF] alpha, interleukin [IL]-1 beta, IL-6, and IL-8), all of which are believed to be of central importance in host proinflammatory and immune responses. Plasma TNF concentrations were increased in 42 patients, plasma IL-1 beta in 15 patients, IL-6 in 194 patients, and IL-8 in 52 patients at presentation. Although admission plasma IL-1 beta, IL-6, and IL-8 concentrations were higher in patients who died in the ICU compared with survivors (n = 33; p &lt; .02, p &lt; .01, p &lt; .02, respectively), only admission plasma IL-8 concentrations were higher in patients with a fatal outcome if all in-hospital deaths were considered (n = 53; p = .05). APACHE III score was the best predictor of mortality (odds ratio 11.41; p = .003). Detection, but not the absolute level, of TNF bioactivity in plasma was a weak independent predictor of death (odds ratio 3.17; p = .02). There was no relationship between bacteremia or presence of the systemic inflammatory response syndrome and plasma cytokine concentrations. Nineteen patients were in the ICU for &gt;or=to10 days, and of these 19 patients, 16 patients had prolonged increases of plasma cytokines. Two patients with persistently increased plasma TNF concentrations died. Otherwise, persistently increased plasma cytokine concentrations had a variable relation to daily APACHE scores and to mortality. CONCLUSIONS Plasma cytokine concentrations fluctuate in serious illness and have a poor correlation with derangement of whole body physiology in seriously ill patients. Only the presence of bioactive TNF in plasma was an independent predictor of mortality. Daily measurement of plasma proinflammatory cytokine concentrations is unlikely to have clinical application in the ICU setting, except possibly in specific subgroups of patients.(Crit Care Med 1996; 24:1775-1781)</abstract><cop>Hagerstown, MD</cop><pub>Williams &amp; Wilkins</pub><pmid>8917024</pmid><doi>10.1097/00003246-199611000-00003</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-3493
ispartof Critical care medicine, 1996-11, Vol.24 (11), p.1775-1781
issn 0090-3493
1530-0293
language eng
recordid cdi_proquest_miscellaneous_78536075
source MEDLINE; Journals@Ovid Complete
subjects Adolescent
Adult
Aged
Aged, 80 and over
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
APACHE
Biological and medical sciences
Cohort Studies
Emergency and intensive cardiocirculatory care. Cardiogenic shock. Coronary intensive care
Female
Humans
Intensive care medicine
Intensive Care Units
Interleukins - blood
Longitudinal Studies
Male
Medical sciences
Middle Aged
Predictive Value of Tests
Prognosis
Prospective Studies
Survival Rate
Systemic Inflammatory Response Syndrome - blood
Systemic Inflammatory Response Syndrome - mortality
Tumor Necrosis Factor-alpha - metabolism
title Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T05%3A13%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Plasma%20proinflammatory%20cytokine%20concentrations,%20Acute%20Physiology%20and%20Chronic%20Health%20Evaluation%20(APACHE)%20III%20scores%20and%20survival%20in%20patients%20in%20an%20intensive%20care%20unit&rft.jtitle=Critical%20care%20medicine&rft.au=Friedland,%20Jon%20S&rft.date=1996-11&rft.volume=24&rft.issue=11&rft.spage=1775&rft.epage=1781&rft.pages=1775-1781&rft.issn=0090-3493&rft.eissn=1530-0293&rft.coden=CCMDC7&rft_id=info:doi/10.1097/00003246-199611000-00003&rft_dat=%3Cproquest_cross%3E78536075%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78536075&rft_id=info:pmid/8917024&rfr_iscdi=true